We also examined human epidermal growth factor receptor 2 (HER2) gene expression in cfDNA and the results were compared with HER2 immunohistochemistry (IHC) status in biopsy, in order to verify whether the cfDNA separated using the PDA-silica hybrids carry the same molecular characteristic to that of the primary tumor. This evidence concerns the gene ERBB2 and neoplasm.